VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Test Product
Phase 1
H
HALEON
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Pain
1 trial
A Phase I, Single-Center, Open-Label, Single-Dose, Pharmacokinetic Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years
Recruiting
·
H
HALEON
·
Phase 1
·
NCT07632274
·
12 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Test Product. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform
—
Drug–disease associations for Test Product. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR
—
HALEON company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Highest Phase
Phase 1
[1]
Company
H
HALEON
Related News